Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Clinical Pharmacology and Therapeutics
|
July 5, 2003
Predicting "real world" effectiveness by integrating adherence with pharmacodynamic modeling
Dyfrig A Hughes, Tom Walley
BMJ (Clinical Research Ed.)
|
November 13, 2004
The pros and cons of essential medicines for rich countries
Marcus M Reidenberg, Tom Walley
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Provider incentives and prescribing behavior in Europe
Elias Mossialos, Tom Walley, Caroline Rudisill
Health Research Policy and Systems
|
January 16, 2022
The qualitative experience of telehealth access and clinical encounters in Australian healthcare during COVID-19: implications for policy
Jennifer White, Julie Byles, Tom Walley
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
February 3, 2015
Patients' expectations of medicines--a review and qualitative synthesis
Ulrica Dohnhammar, Joanne Reeve, Tom Walley
Pharmacoepidemiology and Drug Safety
|
March 16, 2005
Trends and influences on use of antidiabetic drugs in England, 1992-2003
Tom Walley, Dyfrig Hughes, Helen Kendall
Health Research Policy and Systems
|
December 6, 2019
'All the stars were aligned'? The origins of England's National Institute for Health Research
Paul Atkinson, Sally Sheard, Tom Walley
The International Journal of Health Planning and Management
|
December 13, 2005
Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK
Tom Walley, Monique Mrazek, Elias Mossialos
BMJ (Clinical Research Ed.)
|
February 8, 2011
Research to decrease areas of clinical uncertainty
Andrew Farmer, Ruairidh Milne, Tom Walley
Family Practice
|
January 2, 2003
Influences on GPs' decision to prescribe new drugs-the importance of who says what
Helen Prosser, Solomon Almond, Tom Walley
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Clinical Pharmacology and Therapeutics
|
July 5, 2003
Predicting "real world" effectiveness by integrating adherence with pharmacodynamic modeling
Dyfrig A Hughes, Tom Walley
BMJ (Clinical Research Ed.)
|
November 13, 2004
The pros and cons of essential medicines for rich countries
Marcus M Reidenberg, Tom Walley
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Provider incentives and prescribing behavior in Europe
Elias Mossialos, Tom Walley, Caroline Rudisill
Health Research Policy and Systems
|
January 16, 2022
The qualitative experience of telehealth access and clinical encounters in Australian healthcare during COVID-19: implications for policy
Jennifer White, Julie Byles, Tom Walley
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
February 3, 2015
Patients' expectations of medicines--a review and qualitative synthesis
Ulrica Dohnhammar, Joanne Reeve, Tom Walley
Pharmacoepidemiology and Drug Safety
|
March 16, 2005
Trends and influences on use of antidiabetic drugs in England, 1992-2003
Tom Walley, Dyfrig Hughes, Helen Kendall
Health Research Policy and Systems
|
December 6, 2019
'All the stars were aligned'? The origins of England's National Institute for Health Research
Paul Atkinson, Sally Sheard, Tom Walley
The International Journal of Health Planning and Management
|
December 13, 2005
Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK
Tom Walley, Monique Mrazek, Elias Mossialos
BMJ (Clinical Research Ed.)
|
February 8, 2011
Research to decrease areas of clinical uncertainty
Andrew Farmer, Ruairidh Milne, Tom Walley
Family Practice
|
January 2, 2003
Influences on GPs' decision to prescribe new drugs-the importance of who says what
Helen Prosser, Solomon Almond, Tom Walley
Page
of 6